The rhamnolipids market size is projected to reach US$ 53.49 billion by 2031 from US$ 38.14 billion in 2024. The market is expected to register a CAGR of 5.1% during 2025-2031.

Rhamnolipids have gained significant attention in the global market due to their growing demand from various end-use industries.

The rhamnolipids market is driven by growing demand for sustainable and environmentally friendly alternatives to conventional chemical surfactants. Increasing awareness among consumers and industries about the ecological impact of petrochemical-based products has accelerated the adoption of biodegradable and low-toxicity biosurfactants like rhamnolipids. Stringent environmental regulations, particularly in Europe and North America, further encourage manufacturers to replace traditional surfactants with bio-based solutions, especially in personal care, household cleaning, and industrial applications.

Technological advancements in microbial fermentation and downstream processing have enhanced production efficiency, reduced costs, and improved product consistency, making rhamnolipids commercially viable for large-scale applications. Additionally, the versatility of rhamnolipids across multiple industries, including agriculture, oil and gas, pharmaceuticals, food, and environmental remediation, supports market expansion. Their functional properties, such as emulsification, wetting, foaming, and antimicrobial activity, coupled with growing investment in research and development, continue to drive innovation and adoption, ensuring sustained growth in the global rhamnolipids market.

Europe accounts for the largest share of the global rhamnolipids market due to a combination of strong regulatory support, advanced industrial infrastructure, and high consumer awareness of sustainability. Strict environmental regulations under frameworks such as REACH and the European Green Deal have encouraged industries to adopt biodegradable and low-toxicity biosurfactants over conventional chemical surfactants. The region also hosts several leading rhamnolipid manufacturers and biotechnology companies, supported by well-established research and development ecosystems, enabling large-scale production and commercialization. Additionally, European consumers' preference for eco-friendly personal care, household, and industrial products drives demand for bio-based ingredients. Government incentives, funding for green chemistry initiatives, and collaborations between academia and industry further strengthen Europe's position as the dominant rhamnolipids market globally.

Some of the key players operating in the rhamnolipids market include Zhejiang Seedling Bio Co., Ltd; Seebio Biotech (Shanghai) Co Ltd; GlycoSurf; Biotensidon GmbH; Zhejiang Silver-Elephant Bio-engineering Co., Ltd.; Hangzhou Leap Chem Co., Ltd.; Shaanxi Deguan Biotechnology Co., Ltd; Biosynth AG; Evonik Industries AG; Starchem Enterprises Limited; Sihauli Chemicals Private Limited; AGAE Technologies LLC; Merck KGaA; Alfa Chemistry; and Jeneil Biotech Inc. Players operating in the rhamnolipids market focus on providing innovative products at affordable prices to fulfill customer demand.

Primary and secondary sources have derived the overall rhamnolipids market size. To begin the research process, exhaustive secondary research has been conducted using internal and external sources to obtain qualitative and quantitative information related to the market. Also, multiple primary interviews have been conducted with industry participants to validate the data and gain more analytical insights into the topic. The participants of this process include industry experts such as VPs, business development managers, market intelligence managers, and national sales managers-along with external consultants such as valuation experts, research analysts, and key opinion leaders-specializing in the rhamnolipids market.